Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic-Myeloproliferative Diseases

Explore clinical trials studying Myelodysplastic-Myeloproliferative Diseases. Study availability and eligibility vary by location and protocol.

384 public trials 62 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic-Myeloproliferative Diseases trial results

Recruiting

Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT03850574

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +16 more
Locations
  • The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Irvine Irvine, California, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
View all 34 locations
View Trial Details
Recruiting

Pacritinib in CMML

NCT06159491

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +11 more
Locations
  • The Mount Sinai Hospital New York, United States
View Trial Details
Recruiting

Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) Trial

NCT06355583

Conditions
Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukaemia, Acute Myeloid Leukemia, +27 more
Locations
  • University Hospitals Birmingham NHS Foundation Trust Birmingham, England, United Kingdom
  • Leeds Teaching Hospital NHS Trust Leeds, England, United Kingdom
  • University College London Hospitals NHS Trust London, England, United Kingdom
  • Kings College NHS Foundation Trust London, England, United Kingdom
View Trial Details
Recruiting

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

NCT06462365

Conditions
Acute Lymphoblastic Leukemia, Adult B-Cell, Acute Lymphoblastic Leukemia, Adult T-Cell, Acute Myeloid Leukemia in Remission, +40 more
Locations
  • City of Hope Duarte, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Recruiting

Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies

NCT05488548

Conditions
Bone Marrow Diseases, Castrate Resistant Prostate Cancer, Chronic Disease, +16 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Mayo Clinic Rochester Rochester, Minnesota, United States
View Trial Details
Recruiting

Venetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAML

NCT05807932

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +13 more
Locations
  • Universitätsklinikum Aachen - Med. Klinik IV Aachen, North Rhine-Westphalia, Germany
  • Universitätsklinikum Düsseldorf - Klinik für Hämatologie, Onkologie und Klinische Immunologie Düsseldorf, North Rhine-Westphalia, Germany
  • Universitätsklinikum Köln Klinik I für Innere Medizin Cologne, Germany
  • Universitätsklinikum Frankfurt Medizinische Klinik II Frankfurt, Germany
View Trial Details

Related conditions